< LEADERBOARD/s/msmSulfur compounds

MSM

Also sold as: Methylsulfonylmethane · Dimethyl sulfone · Crystalline MSM

A sulfur-containing molecule sold for joint comfort and recovery. Small knee-osteoarthritis trials suggest modest symptomatic improvements, without evidence of cartilage rebuilding.

Longevity

COMMUNITY_STACK_RATINGlive · n=0

Community

Not enough ratings yet: 0 of 10

Scores appear after 10 ratings, so that one or two reports can't dominate. Tried it? Your rating counts.

+ Rate your experience (30 sec, anonymous)

NERD_PROTOCOL // EVIDENCE_MATRIXper goal

Research

LongevityNo established evidence

Longevity: Small skin-appearance studies do not demonstrate longer life or slower systemic aging; human longevity efficacy is unestablished.

REALITY CHECK // MSM has a modest joint-symptom signal in small short-term trials, not proof of cartilage repair or universal detox. Combination trials cannot isolate MSM, while animal tolerability cannot establish safety of consumer megadoses.

Levels: how we grade evidence. Grey = evidence of no benefit; amber = evidence it makes this goal worse.

Ratings are self-reported by a self-selected group of users: how it felt, not proof that it works.

CHECK_YOUR_BOTTLE.EXEruns in your browser · nothing is sent or stored

Check your bottle

Compare what your label says with what was used in trials. This is a trial range, not a personal prescription.

Enter the amount from your label to see the result.

How it was studied

01 // STUDIED_DOSE_RANGE

Trial exposure, not an individual prescription

Knee OA: 1125 mg three times daily (3375 mg/day), n=49, 12 weeks; another pilot used 3000 mg twice daily (6000 mg/day), n=50, 12 weeks. Exercise: 3000 mg/day for 21 days before and two days after a half-marathon, n=22. An open-label allergy study used 2600 mg/day for 30 days.

02 // TIMING_&_MATRIX

Route and formulation matter

The evidence does not establish a superior time of day or a benefit from cycling. Powder and capsules should be compared by whole MSM mass.

03 // EVALUATION_WINDOW

Match the study window

OA trials generally lasted 12 weeks; exercise study 21 days before plus two days after the event; open-label allergy study 30 days.

04 // SAFETY_&_QUALITY_GATE

Clinical review and label check

Human pregnancy/lactation and pediatric dose safety are inadequate. Stop for rash, nausea, diarrhea or persistent bloating. Reported sensitivity should be assessed clinically; nonspecific sulfur intolerance claims do not establish a diagnosis. Review anticoagulant use before high doses.

UPPER LIMIT // No formal EFSA/NIH UL is verified in this dossier. Clinical studies describe roughly 1.5-6 g/day over short/moderate windows; these are not a universal safe ceiling. Rat 90-day NOAEL of 1.5 g/kg/day must not be converted into consumer dosing.

NERD'S NOTENerd Protocols · a clinical and sports dietitian based in the EU

Summary

Knee-osteoarthritis evidence is the strongest part of this dossier but consists mainly of small, 12-week trials. Exercise outcomes are small surrogate studies; allergy and skin claims are preliminary, sometimes uncontrolled or confounded by combination products.

Mechanism

MSM supplies organic sulfur and has proposed redox/inflammatory effects. Animal PK demonstrates tissue distribution, not verified human superiority or a requirement for absorption enhancers.

Typical studied dose

Upper limit

No formal EFSA/NIH UL is verified in this dossier. Clinical studies describe roughly 1.5-6 g/day over short/moderate windows; these are not a universal safe ceiling. Rat 90-day NOAEL of 1.5 g/kg/day must not be converted into consumer dosing.

POPULAR_STACKScombos with n ≥ 5

Popular stacks with MSM

Not enough stack data yet. A combination with MSM appears here once 5 people rate the same set.

> Rate my stack

Forms and label traps

Forms compared
Form on label	Active content	Studied range / day	Absorption & GI tolerance	Verdict
Crystalline MSM powder / capsules Best for: Matching the small MSM-only knee OA trials.	Extract weight · marker not quantified	3375–6000 mg	Single molecule; rodent PK shows absorption/distribution but is not human PK. GI upset increases at higher doses.	Studied standard [FORM // REFERENCE] Trials dose whole MSM mass, not elemental sulfur. Its approximately 34% chemical sulfur content must not scale an MSM trial target. PMID 21708034 PMID 16309928
Distilled branded MSM Best for: Documented purity testing and quality control.	Extract weight · marker not quantified	3375–6000 mg	Same MSM molecule; no human superiority in absorption established. No established advantage over other pure MSM.	Good option [FORM // GOOD] Distillation/branding does not change the molecule or prove better clinical effects. Same-molecule trial range is a comparison, not product-specific validation.

Common label traps

TRAP_01 // 34% SULFUR MEANS DOSE ONLY THE SULFUR
The OA trial amounts refer to whole MSM. A sulfur-content conversion would mismatch the evidence.
TRAP_02 // REBUILDS CARTILAGE
Clinical endpoints are pain/function, not structural cartilage regeneration.
TRAP_03 // MORE IS BETTER BECAUSE IT IS NONTOXIC
Rat toxicity data do not validate tens of grams daily in people. Higher exposure can increase GI symptoms.
TRAP_04 // A JOINT STACK PROVES MSM WORKS
Combined products cannot isolate the contribution of MSM; assess the small MSM-only trials separately.

Other outcomes studied

Outside the five leaderboard goals. Same evidence levels as above.

Knee OA symptoms: MSM alone Moderate · benefit
Debbi: n=49, 3375 mg/day, 12 weeks; physical-function difference 14.6 mm (CI 4.3-25.0), p=0.04. Kim: n=50, 6000 mg/day, 12 weeks; pain/function improved (p<0.05), stiffness and total score did not. The review pooled DMSO/MSM evidence in 681 patients; small trials and mixed products limit certainty.
PMID 21708034 PMID 16309928 PMID 18417375
Knee OA: combinations Limited · benefit
Glucosamine/chondroitin or boswellic-acid combinations show symptom signals, but do not establish the isolated contribution of MSM.
PMID 28790224 PMID 26684635 PMID 21986780
Exercise recovery markers Limited · benefit
Half-marathon trial n=22 used 3000 mg/day for 21 days before plus two days after; oxidative-stress markers and soreness trends were mixed. Other small studies examined damage/antioxidant markers or immune mRNA. No established performance benefit; this is not anxiety evidence.
PMID 28736511 PMID 22525653 PMID 40507030
Seasonal allergic rhinitis Anecdotal · benefit
An open-label study had 50 completers, 2600 mg/day for 30 days, with symptom improvement from day seven but no placebo. An exploratory blinded allergen-challenge trial remains preliminary.
PMID 12006124 PMID 30497995
Skin appearance Anecdotal · benefit
Small studies report selected skin-appearance changes; the hyaluronic-acid/L-carnosine/MSM study tests a combination. These cosmetic outcomes do not demonstrate systemic longevity.
PMID 32083522 PMID 31119010
Preclinical PK and safety No established evidence
Rat absorption/distribution and a 90-day 1.5 g/kg/day toxicity study contextualize safety, not human efficacy or a safe megadose.
PMID 17263509 PMID 12387309

Reader questions

What dose actually worked for joints?

The two small 12-week MSM-only studies used 3375 and 6000 mg/day. These study exposures do not establish that more is better or that an individual should use them.

Does it work alone or only in a joint stack?

There are small MSM-only trials, but many marketed findings come from combinations that cannot isolate MSM.

Powder, capsules or distilled MSM?

Powder and capsules can contain the same molecule. Prioritize product identity and purity testing; no clinical absorption superiority of branded distilled MSM is established.

Should I cycle it?

The dossier has no controlled evidence for cycling. Trials lasting around 12 weeks do not establish benefits or safety of years of use.

What if I take blood-thinning medicine?

The interaction is not confirmed in RCTs, but high-dose use warrants prescriber review rather than assuming safety.

Stack interactions

Caution Anticoagulants / antiplatelets [CAUTION // REVIEW_CONTEXT]
Possible bleeding effects at high doses are theoretical/anecdotal without confirmation in RCT interaction studies. Review use with the prescriber.
Caution Glucosamine, chondroitin and boswellia [CAUTION // REVIEW_CONTEXT]
Combination trials suggest symptom changes but cannot establish an isolated MSM contribution or synergy.
PMID 28790224 PMID 26684635 PMID 21986780
Caution Collagen, vitamin C and hyaluronic acid [CAUTION // REVIEW_CONTEXT]
Beauty/joint combinations have mechanistic appeal; effects cannot be assigned to MSM alone.
PMID 31119010

Red flags: interactions and who should avoid it

Interactions

A bleeding interaction with anticoagulants/antiplatelets is weakly supported and largely theoretical/anecdotal; review high-dose use and monitor clinically. Glucosamine/chondroitin, boswellia, collagen, vitamin C and hyaluronic acid combinations do not prove MSM-specific synergy.

Avoid or ask a doctor first if

Sources (PubMed, 15)

Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study.
PMID 21708034 · 2011 · Randomized controlled trial
Debbi: n=49, 3375 mg/day, 12 weeks; physical-function difference 14.6 mm (CI 4.3-25.0), p=0.04. Kim: n=50, 6000 mg/day, 12 weeks; pain/function improved (p<0.05), stiffness and total score did not. The review pooled DMSO/MSM evidence in 681 patients; small trials and mixed products limit certainty. Single molecule; rodent PK shows absorption/distribution but is not human PK. Trials dose whole MSM mass, not elemental sulfur. Its approximately 34% chemical sulfur content must not scale an MSM trial target.
Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial.
PMID 16309928 · 2006 · Randomized controlled trial
Debbi: n=49, 3375 mg/day, 12 weeks; physical-function difference 14.6 mm (CI 4.3-25.0), p=0.04. Kim: n=50, 6000 mg/day, 12 weeks; pain/function improved (p<0.05), stiffness and total score did not. The review pooled DMSO/MSM evidence in 681 patients; small trials and mixed products limit certainty. Single molecule; rodent PK shows absorption/distribution but is not human PK. Trials dose whole MSM mass, not elemental sulfur. Its approximately 34% chemical sulfur content must not scale an MSM trial target.
Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritis.
PMID 18417375 · 2008 · Systematic review and meta-analysis
Debbi: n=49, 3375 mg/day, 12 weeks; physical-function difference 14.6 mm (CI 4.3-25.0), p=0.04. Kim: n=50, 6000 mg/day, 12 weeks; pain/function improved (p<0.05), stiffness and total score did not. The review pooled DMSO/MSM evidence in 681 patients; small trials and mixed products limit certainty.
Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial.
PMID 28790224 · 2017 · Randomized controlled trial
Glucosamine/chondroitin or boswellic-acid combinations show symptom signals, but do not establish the isolated contribution of MSM. Combination trials suggest symptom changes but cannot establish an isolated MSM contribution or synergy.
Methylsulfonylmethane and boswellic acids versus glucosamine sulfate in the treatment of knee arthritis: Randomized trial.
PMID 26684635 · 2016 · Randomized controlled trial
Glucosamine/chondroitin or boswellic-acid combinations show symptom signals, but do not establish the isolated contribution of MSM. Combination trials suggest symptom changes but cannot establish an isolated MSM contribution or synergy.
The \"MESACA\" study: methylsulfonylmethane and boswellic acids in the treatment of gonarthrosis.
PMID 21986780 · 2011 · Randomized controlled trial
Glucosamine/chondroitin or boswellic-acid combinations show symptom signals, but do not establish the isolated contribution of MSM. Combination trials suggest symptom changes but cannot establish an isolated MSM contribution or synergy.
Effects of Methylsulfonylmethane (MSM) on exercise-induced oxidative stress, muscle damage, and pain following a half-marathon: a double-blind, randomized, placebo-controlled trial.
PMID 28736511 · 2017 · Randomized controlled trial
Half-marathon trial n=22 used 3000 mg/day for 21 days before plus two days after; oxidative-stress markers and soreness trends were mixed. Other small studies examined damage/antioxidant markers or immune mRNA. No established performance benefit; this is not anxiety evidence.
Effect of methylsulfonylmethane supplementation on exercise - Induced muscle damage and total antioxidant capacity.
PMID 22525653 · 2012 · Randomized controlled trial
Half-marathon trial n=22 used 3000 mg/day for 21 days before plus two days after; oxidative-stress markers and soreness trends were mixed. Other small studies examined damage/antioxidant markers or immune mRNA. No established performance benefit; this is not anxiety evidence.
Using the Rise and Fall of Oxidative Stress and Inflammation Post-Exercise to Evaluate the Effect of Methylsulfonylmethane Supplementation on Immune Response mRNA.
PMID 40507030 · 2025 · Randomized controlled trial
Half-marathon trial n=22 used 3000 mg/day for 21 days before plus two days after; oxidative-stress markers and soreness trends were mixed. Other small studies examined damage/antioxidant markers or immune mRNA. No established performance benefit; this is not anxiety evidence.
A multicentered, open-label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitis.
PMID 12006124 · 2002 · Human pilot study
An open-label study had 50 completers, 2600 mg/day for 30 days, with symptom improvement from day seven but no placebo. An exploratory blinded allergen-challenge trial remains preliminary.
Evaluating the Impacts of Methylsulfonylmethane on Allergic Rhinitis After a Standard Allergen Challenge: Randomized Double-Blind Exploratory Study.
PMID 30497995 · 2018 · Randomized controlled trial
An open-label study had 50 completers, 2600 mg/day for 30 days, with symptom improvement from day seven but no placebo. An exploratory blinded allergen-challenge trial remains preliminary.
Beauty from within: Oral administration of a sulfur-containing supplement methylsulfonylmethane improves signs of skin ageing.
PMID 32083522 · 2022 · Randomized controlled trial
Small studies report selected skin-appearance changes; the hyaluronic-acid/L-carnosine/MSM study tests a combination. These cosmetic outcomes do not demonstrate systemic longevity.
Randomized, Placebo-controlled Study of a Nutraceutical Based on Hyaluronic Acid, L-carnosine, and Methylsulfonylmethane in Facial Skin Aesthetics and Well-being.
PMID 31119010 · 2019 · Randomized controlled trial
Small studies report selected skin-appearance changes; the hyaluronic-acid/L-carnosine/MSM study tests a combination. These cosmetic outcomes do not demonstrate systemic longevity. Beauty/joint combinations have mechanistic appeal; effects cannot be assigned to MSM alone.
Pharmacokinetics and distribution of [35S]methylsulfonylmethane following oral administration to rats.
PMID 17263509 · 2007 · Preclinical animal study
Rat absorption/distribution and a 90-day 1.5 g/kg/day toxicity study contextualize safety, not human efficacy or a safe megadose.
Toxicity of methylsulfonylmethane in rats.
PMID 12387309 · 2002 · Preclinical animal study
Rat absorption/distribution and a 90-day 1.5 g/kg/day toxicity study contextualize safety, not human efficacy or a safe megadose.

Community comments

No approved comments yet. Comments are held for moderation.

+ Rate this

MSM